Natural killer T cells: Rapid responders controlling immunity and disease

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 7, 2005, Pages 1337-1343

  Mercer, Jason C ^a   Ragin, Melanie J ^a   August, Avery ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

CD1d; Cytokines; Immune response; Interleukin 4; Galactosylceramide

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ATHEROSCLEROSIS; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DIABETES MELLITUS; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; REVIEW; STEM CELL; T LYMPHOCYTE; THYMOCYTE; TUMOR REJECTION; VIRUS INFECTION;

EID: 17044409102     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.11.019     Document Type: Short Survey

References (36)

1. S. Berzins, A. Uldrich, D. Pellicci, F. Mcnab, Y. Kayakawa, and M. Smyth Parallels and distinctions between T and NKT cell development in the thymus Immunol Cell Biol 82 2004 269 275
2. L. Bilenki, J. Yang, Y. Fan, S. Wang, and X. Yang Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production Eur J Immunol 34 2004 345 354
3. N. Crowe, A. Uldrich, K. Kyparissoudis, K. Hammond, Y. Hayakawa, and S. Sidobre Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells J Immunol 171 2003 4020 4027
4. M. Emoto, and S. Kaufmann Liver NKT cells: An account of heterogeneity TRENDS Immunol 24 2003 364 369
5. L. Esteban, T. Tsoutsman, M. Jordan, D. Roach, L. Poulton, and A. Brooks Genetic control of NKT cell numbers maps to major diabetes and lupus loci J Immunol 171 2003 2873 2878
6. M. Falcone, B. Yeung, L. Tucker, E. Rodriguez, and N. Sarvetnick A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in non-obese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus J Exp Med 190 1999 963 972
7. S. Fujii, K. Shimizu, M. Kronenberg, and R. Steinman Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs Nat Immunol 3 2002 867 874
8. P. Gadue, and P. Stein NKT cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation J Immunol 169 2002 2397 2406
9. G. Giaccone, C. Punt, Y. Ando, R. Ruijter, N. Nishi, and M. Peters A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors Clin Cancer Res 8 2002 3702 3709
10. D. Godfrey, K. Hammond, L. Poulton, M. Smyth, and A. Baxter NKT cells: Facts, functions and fallacies Immunol Today 21 2000 573 583
11. B. Grubor-Bauk, A. Simmons, G. Mayrhofer, and P. Speck Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR J Immunol 170 2003 1430 1434
12. J. Gumperz, S. Miyake, T. Yamamura, and M. Brenner Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining J Exp Med 195 2002 625 636
13. D. Hansen, and L. Schofield Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells Int J Parasitol 34 2004 15 25
14. L. Ho, B. Urban, L. Jones, G. Ogg, and A. Mcmichael CD4-CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion J Immunol 172 2004 7350 7358
15. S. Hong, M. Wilson, I. Serizawa, L. Wu, N. Singh, and O. Naidenko The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice Nat Med 7 2001 1052 1056
16. K. Ito, M. Karasawa, T. Kawano, T. Akasaka, H. Koseki, and Y. Akutsu Involvement of decidual Valpha14 NKT cells in abortion Proc Natl Acad Sci USA 97 2000 740 744
17. A. Jahng, I. Maricic, B. Pedersen, N. Burdin, O. Naidenko, and M. Kronenberg Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis J Exp Med 194 2001 1789 1799
18. M. Jordan, J. Fletcher, and A. Baxter Genetic control of NKT cell numbers Immunol Cell Biol 82 2004 276 284
19. K. Kakimi, L. Guidotti, Y. Koezuka, and F. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 2000 921 930
20. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, and H. Sato Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells Proc Natl Acad Sci USA 95 1998 5690 5693
21. P. Lee, A. Putnam, K. Benlagha, L. Teyton, P. Gottlieb, and A. Bendelac Testing the NKT cell hypothesis of human IDDM pathogenesis J Clin Invest 110 2002 793 800
22. M. Lisbonne, S. Diem, A. De Castro Keller, J. Lefort, L. Araujo, and P. Hachem Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model J Immunol 171 2003 1637 1641
23. Q. Mi, D. Ly, P. Zucker, M. Mcgarry, and T. Delovitch Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells Diabetes 53 2004 1303 1310
24. Q. Mi, C. Meagher, and T. Delovitch CD1d-restricted NKT regulatory cells: Functional genomic analyses provide new insights into the mechanisms of protection against type 1 diabetes Novartis Found Symp 252 2003 146 160
25. Y. Nakai, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, and K. Watano Natural killer T cells accelerate atherogenesis in mice Blood 104 2004 2051 2059 Epub 2004 Apr 27
26. M. Nieda, M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, and K. Ide Therapeutic activation of V alpha24+V beta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity Blood 103 2004 383 389
27. D. Pellicci, K. Hammond, A. Uldrich, A. Baxter, M. Smyth, and D. Godfrey A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage J Exp Med 195 2002 835 844
28. S. Sharif, G. Arreaza, P. Zucker, Q. Mi, J. Sondhi, and O. Naidenko Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes Nat Med 7 2001 1057 1062
29. M. Skold, and S. Behar Role of CD1d-restricted NKT cells in microbial immunity Infect Immun 71 2003 5447 5455
30. M. Stenstrom, M. Skold, A. Ericsson, L. Beaudoin, S. Sidobre, and M. Kronenberg Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type Eur J Immunol 34 2004 56 65
31. D. Stetson, M. Mohrs, R. Reinhardt, J. Baron, Z. Wang, and L. Gapin Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function J Exp Med 198 2003 1069 1076
32. E. Tupin, A. Nicoletti, R. Elhage, M. Rudling, H. Ljunggren, and G. Hansson CD1d-dependent activation of NKT cells aggravates atherosclerosis J Exp Med 199 2004 417 422
33. L. Van Kaer Natural killer T cells as targets for immunotherapy of autoimmune diseases Immunol Cell Biol 82 2004 315 322
34. Y. Yang, M. Bao, and J. Yoon Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse Diabetes 50 2001 2691 2699
35. D. Zeng, Y. Liu, S. Sidobre, M. Kronenberg, and S. Strober Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus J Clin Invest 112 2003 1211 1222
36. D. Zhou, J. Mattner, C. Cantu Iii, N. Schrantz, N. Yin, and Y. Gao Lysosomal glycosphingolipid recognition by NKT cells Science 306 2004 1786 1789 Epub 2004 Dec 3